Videos
Presenter: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American…
Read MoreValeant Pharmaceuticals is undergoing increased scrutiny. A year ago, J. Michael Pearson, then president and CEO, laid out the company’s vision for developing new tools…
Read MoreModerator: Tom Salemi Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications…
Read MoreView PDF Presentation Presenter: Dorit B. Donoviel, PhD Dr. Donoviel oversees the diverse portfolio of science and technology research and development projects at NSBRI that…
Read MoreWaveTec CEO Tom Frinzi spoke to the ease of the deal that paired his company with Alcon, hints at plans for the future and explains…
Read MoreLaurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the…
Read MoreJeff George, Global Head of Alcon, took a few minutes between panels and meetings to share his vision for innovation at Alcon and how the…
Read MoreFirst adopter Richard Lindstrom, MD, details the role new technology play in ophthalmology. Speaking With: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending…
Read MoreMichael Brownell, CEO of Gobiquity, explains how his company is turning smartphones into a critical diagonstic tool to treat pediatric vision. Speaking With: Michael Brownell…
Read MoreHighlights of a discussion between the ophthalmology sector’s top execs about how to do M&A right. Moderator: Jim Mazzo Jim Mazzo is the Executive Chairman…
Read MoreA panel of ophthalmology executives at the Ophthalmology Innovation Summit discuss the perks and pitfalls of going public. Moderator: David Guyer, MD Under Dr. Guyer’s…
Read MoreGoogle and Alcon executives shared the stage to answer some questions about thier unique partnership. Alcon executives Laurent Attias, Head, Global Commercial Strategy and Franck…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.